Tab. I.
Organization | Visceral obesity | TAG | HDL | Blood pressure (BP) | Fasting plasma glucose | Other | Reference |
---|---|---|---|---|---|---|---|
• World Health Organization (WHO) • Diabetes, IR or impaired glucose tolerance PLUS two or more other criteria. |
Body mass index > 30 kg/m2 Waist hip ratio For males > 0.9 For females > 0.85 |
≥ 150 mg/dL |
For males < 35 mg/dL For females < 39 mg/dL |
≥ 140/90 mmHg | Impaired glucose tolerance or diabetes and/or IR |
Microalbuminuria Urinary albumin excretion rate ≥ 20 μg/min Albumin creatine ratio ≥ 30 μg/mg |
WHO [18] |
– International Diabetes Federation (IDF) – Visceral obesity PLUS two or more other criteria. |
Waist circumference Defined with ethnic-specific values |
≥ 150 mg/dL (1.7 mmol/L) or specific treatment for this abnormality |
For males < 40 mg/dL (1.03 mmol/L) For females < 50 mg/dL (1.29 mmol/L) or specific treatment for this abnormality |
Systolic BP ≥ 130 mmHg or Diastolic BP ≥ 85 mmHg or treatment of previously diagnosed hypertension |
≥ 100 mg/dL (5.6 mmol/L) or previously diagnosed with type II diabetes |
- | IDF [19] |
- American Heart Association (AHA) - At least three criteria. |
Waist circumference For males ≥ 102 cm (≥40 inches) For females ≥ 88 cm (≥ 35 inches) |
≥ 150 mg/dL (1.7 mmol/L) or specific treatment for this abnormality |
For males < 40 mg/dL (1.03 mmol/L) For females < 50 mg/dL (1.29 mmol/L) or specific treatment for this abnormality |
Systolic BP ≥ 130 mm Hg or Diastolic BP ≥ 85 mmHg or treatment of previously diagnosed hypertension |
≥ 100 mg/dL or specific treatment for this abnormality |
- | Grundy et al. [20] Alberti et al. [21] AHA [22] |